Full-Spectrum relief for all Bipolar I symptoms in

Depressive and Acute Manic or Mixed Episodes in Adults1,4-6

Screening is an important first step in obtaining a proper diagnosis of bipolar I disorder

The Rapid Mood Screener (RMS) is a mood screener that uses patient-reported answers to help uncover bipolar I disorder.22*

*Disclaimer: AbbVie funded and contributed to the development of this screening tool. This screening tool is not a diagnostic tool. Other screening tools for bipolar I disorder are available, such as the Mood Disorder Questionnaire (MDQ).

No matter the bipolar I episode, VRAYLAR is approved to treat it1

Bipolar I Depression28,30

Depression with or without Manic symptoms:


Depressive symptoms are the most common reason bipolar I patients seek care32

Bipolar I Mania28,30

MANIA with or without depressive symptoms:


Manic symptoms are underreported and often underdiagnosed33,34

Gauge icon depicting VRAYLAR is approved to treat a number of bipolar I episode symptoms.

The approval of VRAYLAR for the treatment of bipolar I depression and acute manic or mixed episodes of bipolar I was based on the change from baseline in total score, not individual symptom measurement, on the MADRS and the YMRS, respectively.1

VRAYLAR is proven to treat the depressive and acute manic or mixed episodes of bipolar I disorder in adults.1

MADRS=Montgomery-Asberg Depression Rating Scale; YMRS=Young Mania Rating Scale.